By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

NovoCure Ltd. 



Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Medical Device






Company News
NovoCure Receives Humanitarian Use Device Designation For Treatment Of Pleural Mesothelioma 5/15/2017 6:08:43 AM
Martin J. Madden Joins NovoCure Board Of Directors 5/11/2017 8:23:02 AM
NovoCure Release: Combination Of Optune With Standard Of Care Chemotherapy, Temozolomide, Delayed Decline In Several Health-Related Quality Of Life Scales Compared To Temozolomide Alone For Newly Diagnosed Glioblastoma Patients 5/8/2017 6:15:26 AM
NovoCure Announces Opening Of Two Pilot Trials To Evaluate The Use Of TTFields For Pediatric Gliomas 5/4/2017 6:28:42 AM
NovoCure Reports First Quarter 2017 Financial Results And Provides Company Update 4/27/2017 5:39:43 AM
NovoCure Announces Four Presentations On Tumor Treating Fields At American Academy of Neurology Annual Meeting In Boston 4/19/2017 6:15:35 AM
NovoCure Release: CNS Oncology Publishes Data Suggesting Survival Benefit Of Optune In Combination With Second Line Chemotherapies After Glioblastoma Recurrence 4/17/2017 9:29:00 AM
NovoCure Release: Combination Of Optune With Standard Of Care Chemotherapy, Temozolomide, Provides Landmark Five-Year Survival Rates For Newly Diagnosed Glioblastoma Patients 4/3/2017 9:54:51 AM
NovoCure Enrolls Last Patient In STELLAR Trial Testing Tumor Treating Fields In Combination With Standard Of Care Chemotherapy In Mesothelioma 3/31/2017 6:16:22 AM
NovoCure To Report First Quarter 2017 Financial Results 3/28/2017 6:42:45 AM
12345678910...
//-->